This federal contract award, valued at $7,144.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with a completion date of December 10, 2024. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/16/25, 12:54 AM